Fluicell AB (publ)
Research Fluicell AB (publ) (5J90) on Bullrun: market cap EUR 4.05M, P/E 0.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker5J90
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 4.05M
- P/E0.0
- Financial periodQ4 2025
- RevenueEUR 3.84M
- Net incomeEUR 101.00K
- Free cash flowEUR 1.27M
- Gross margin132.0%
Valuation Snapshot
latest market cap is EUR 4.05M; P/E is 0.0.
About Fluicell AB (publ)
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds;
Frequently asked questions
What is Fluicell AB (publ)'s market cap?
Fluicell AB (publ)'s market capitalization is EUR 4.05M.
What is Fluicell AB (publ)'s P/E ratio?
Fluicell AB (publ)'s price-to-earnings (P/E) ratio is 0.0.
What does Fluicell AB (publ) do?
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics;